Seed VC · UK
Check size: $15M to $30M
Working with entrepreneurs to turn breakthrough science into breakthrough medicine. Abingworth helps young biopharma companies turn the latest scientific discoveries into dozens of new treatments for patients by providing time, patience, determination, experience and capital.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Enterprise
Geography
US, UK, Europe
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Abingorwth writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Abingorwth alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Abingorwth is one of them, and we'll tell you exactly where they sit in your top 100.